New pulsed field ablation device aims to tame stubborn heart rhythm disorder

NCT ID NCT07281521

Ongoing Disease control Sponsor: CardioFocus Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 04, 2026 · Updated 2 times

Summary

This study tests a new device that uses pulsed electric fields to treat persistent atrial fibrillation, a type of irregular heartbeat. Researchers will enroll 200 people to see if the procedure is safe and can restore normal heart rhythm. The goal is to offer a more precise and less risky alternative to standard treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: pulsed field ablation device
What this could lead to: If successful, this could offer a safer, more effective way to treat persistent atrial fibrillation and reduce the need for lifelong medication.
What could go wrong: This is an early-stage device trial with 200 participants. Risks include serious complications like stroke or heart damage, and long-term success is not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAROXYSMAL ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation paroxysmal atrial fibrillation persistent atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PERSISTANT ATRIAL FIBRILLATION

Contacts and locations

Locations

Homolka

Prague, Czechia
KBC Split

Split, Croatia
St. Anne's University Hospital

Brno, Czechia

More trials for these conditions

Other studies related to the condition(s) this trial covers.